2023 Form 5500 filing — Leidos Biomedical Research, Inc. Retirement Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010102218NAL0020814977001) for Leidos Biomedical Research, Inc. Retirement Plan, reported by Leidos Biomedical Research, Inc. under EIN 33-0653185 and plan number 001. It reports 1,704 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241010102218NAL0020814977001
Filing year
2023
Form type
2
Plan sponsor
Leidos Biomedical Research, Inc.
EIN
33-0653185
Plan number
001
Location
Frederick, MD
Participants
1,704
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$237,976,729
Total liabilities (EOY)
$0
Net assets (EOY)
$237,976,729
Employer contributions
$3,100,000
Total income / additions
$31,636,928
Benefits paid
$12,255,573
Administrative expenses
$1,859,655
Total expenses
$14,115,228
Net increase / (decrease)
$17,521,700
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
MercerNONE$251,747not reported in the loaded dataset
Mercer Investment Consulting, Inc.NONE$143,245not reported in the loaded dataset
Prudential Trust Co.NONE$91,687not reported in the loaded dataset
State Street Bank & Trust CompanyDIRECTED TRUSTEE$58,281$0
VanguardNONE$35,000$0

Related Form 5500 pages